Empresa Xtl Biopharma TEL AVIV STOCK EXCHANGE
Acciones
IL0010854979
Biotecnología e investigación médica
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Shlomo Shalev
CEO | Chief Executive Officer | 62 | 30/12/14 |
Itay Weinstein
DFI | Director of Finance/CFO | 52 | 01/01/99 |
Doron Turgeman
CHM | Chairman | 56 | 30/12/14 |
Daphna Paran
CTO | Chief Tech/Sci/R&D Officer | - | 04/03/16 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Shlomo Shalev
CEO | Chief Executive Officer | 62 | 30/12/14 |
Director/Board Member | 57 | 29/01/20 | |
Director/Board Member | 53 | 01/04/17 | |
Doron Turgeman
CHM | Chairman | 56 | 30/12/14 |
Director/Board Member | 46 | 08/12/14 | |
Director/Board Member | 57 | 01/03/15 | |
Director/Board Member | 63 | 08/12/14 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 514 205 799 | 479 737 353 ( 93,30 %) | 0 | 93,30 % |
Información de la empresa
XTL Biopharmaceuticals Ltd.
26 Ben-Gurion Street
5112001, Ramat Gan
+972 3 611 6600
http://www.xtlbio.com![Dirección Xtl Biopharma](https://cdn.zonebourse.com/static/address/10619579.png)
Sector
Varia. 1 de ene. | Capi. | |
---|---|---|
+25,83 % | 46,56 mil M | |
+45,38 % | 41,67 mil M | |
+0,69 % | 41,16 mil M | |
+30,52 % | 32,4 mil M | |
+22,30 % | 28,18 mil M | |
-6,35 % | 28,1 mil M | |
+49,25 % | 14,52 mil M | |
+49,18 % | 13,74 mil M | |
+3,45 % | 12,17 mil M |